4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031096
Director acquired 1,232,910 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Manning Paul B Director | 2021-07-29 | Conversion | +679,158 | 679,158 | I: show line 1 in the form | ||
| Manning Paul B Director | 2021-07-29 | Conversion | +553,752 | 553,752 | I: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Manning Paul B Director | 2021-07-29 | Conversion · Series B Preferred Stock | −1,669,303 | 0 | I: show line 3 in the form | ||
| Manning Paul B Director | 2021-07-29 | Conversion · Series B Preferred Stock | −1,361,069 | 0 | I: show line 4 in the form |
Loading xslF345X03/doc4.xml…